The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032, registering a CAGR of 7.47% during 2024--2032. Growth is underpinned by ...
Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果